Breakingviews: Drugged up on M&A (2:49)
July 1 - Richard Beales talks to Rob Cyran about Onyx’s search for a buyer and why the cancer drug maker was right to reject Amgen’s $10 bln hostile bid. ( Transcript )
Hard-edged reporting, insight and analysis, Reuters TV breaks ground creating informative news and financial videos. Showcasing Reuters’ 3000 award-winning journalists, Reuters TV delivers high-energy investigative journalism with concise explanations. Check it out and let us know what you think.